Morgan Stanley Maintains Overweight on Doximity, Lowers Price Target to $35

Benzinga Newsdesk www.benzinga.com Neutral 50.3%

Neg 0% Neu 50.3% Pos 0%

Morgan Stanley analyst Ricky Goldwasser maintains Doximity (NYSE:DOCS) with a Overweight and lowers the price target from $49 to $35.